Redefining the therapeutic goals in chronic lymphocytic leukemia: towards an evidence-based, risk-adapted therapy.
Medizinische Klinik III, Klinikum Grosshadern, Germany.
C M
CM
Wendtner
B
B
Schmitt
M
M
Wilhelm
P
P
Dreger
E
E
Montserrat
B
B
Emmerich
M
M
Hallek
D001424:Bacterial Infections / Q000517:prevention & control; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D014740:Vidarabine / Q000031:analogs & derivatives / Q000627:therapeutic use
D014740:Vidarabine; C024352:fludarabine